Kevin P. Finney's most recent trade in Vaxart Inc was a trade of 50,000 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on July 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Vaxart Inc | Kevin P. Finney | Director | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 17 Jul 2025 | 50,000 | 204,771 (0%) | 0% | 0.4 | 18,500 | Common Stock |
Vaxart Inc | Kevin P. Finney | Director | Purchase of securities on an exchange or from another person at price $ 0.35 per share. | 17 Jul 2025 | 50,000 | 154,771 (0%) | 0% | 0.4 | 17,500 | Common Stock |
Vaxart Inc | Kevin P. Finney | Director | Purchase of securities on an exchange or from another person at price $ 0.38 per share. | 17 Jul 2025 | 25,874 | 104,771 (0%) | 0% | 0.4 | 9,832 | Common Stock |
Vaxart Inc | Kevin P. Finney | Director | Purchase of securities on an exchange or from another person at price $ 0.40 per share. | 17 Jul 2025 | 20,000 | 78,897 (0%) | 0% | 0.4 | 8,000 | Common Stock |
Vaxart Inc | Kevin P. Finney | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 17 Jul 2025 | 20,000 | 58,897 (0%) | 0% | 0.4 | 7,800 | Common Stock |
Vaxart Inc | Kevin P. Finney | Director | Purchase of securities on an exchange or from another person at price $ 0.38 per share. | 17 Jul 2025 | 794 | 38,897 (0%) | 0% | 0.4 | 302 | Common Stock |
Vaxart Inc | Kevin P. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 36,392 | 36,392 | - | - | Stock Option (right to buy) | |
Vaxart Inc | Kevin P. Finney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 6,103 | 38,103 (0%) | 0% | 0 | Common Stock | |
Vaxart Inc | Kevin Finney P. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 190,800 | 190,800 | - | - | Stock Option (right to buy) | |
Vaxart Inc | Kevin Finney P. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 32,000 | 32,000 (0%) | 0% | 0 | Common Stock |